Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Aurobindo Pharma Limited | Medchal, India | Makes it and tests it | Problems found, fixed voluntarilyJul 21, 2023 · 13 inspections, 1 with FDA action |
| Aurobindo Pharma Limited | Mahabubnagar, India | Makes it and tests it | Problems found, fixed voluntarilyMay 10, 2022 · 7 inspections, 1 with FDA action |
| Aurolife Pharma LLC | Dayton, NJ, United States | Makes it and tests it | Serious problems, FDA actionDec 7, 2021 · 10 inspections, 1 with FDA action |
| Aurovitas Pharma Taizhou Co.,LTD | Taizhou, China | Makes it and tests it | Not inspected on record |
Recalls
- Mar 18, 2020 · Class II · Aurobindo Pharma USA Inc.
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Lots: Lot #: 05319004A1, Exp. Date 03/2022 - Jul 29, 2019 · Class III · Aurobindo Pharma USA Inc.
Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B
Lots: 05318054B, exp 3/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Simvastatin: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA077691
- On the market since
- Dec 20, 2006
- Package NDCs
65862-050-0065862-050-0165862-050-2665862-050-3065862-050-4565862-050-9065862-050-99- Official label
- DailyMed (National Library of Medicine), updated May 11, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?